Agenda

Friday, December 6, 2024—Eastern Time Zone

7:00 AM - 8:00 AM Registration and Breakfast/Coffee Talk with Key Opinion Leaders

In-person learners are invited to start off the morning with Key Opinion Leaders as well as other colleagues to enjoy coffee and informal discussions about a hot topic related to mood disorders.

8:00 AM - 8:10 AM: Opening Remarks by Moderator Lisa Harding, MD

8:10 AM - 9:10 AM: Keynote Session: Do Obesity and Diabetes Mellitus Metastasize to the Brain? "Metaboptosis" and Implications for Potential Therapeutics in Psychiatry – Presented by Roger McIntyre, MD

In this compelling session, we will explore the medical interface of GLP-1 agonists with psychiatric disorders including the neurobiological overlap of medical disorders and psychiatric disorders and the potential for therapeutic overlap focusing on anti-inflammatories and novel anti-diabetic agents as psychiatric treatments. Once we understand the role of GLP in normal brain function, we will discuss the role of metabolism in the pathology, phenomenology and comorbidity of psychiatric disorders and dive into the data supporting the targeting of metabolic proteins, including GLP, as possibly innovative, mechanistically informed treatment options in psychiatry.

10-Minute Break

9:20 AM - 10:20 AM: Non-CME Educational Session managed by MDOutlook / Clinical Care Solutions, a CEA Company

The Patient Journey Through Bipolar II Depression Sponsored by Intra-Cellular Therapies, Inc.– Presented by Heather Luing, MD

This program explores features of bipolar II depression that differentiate it from major depressive disorder. After exploring the patient journey, learn more about a treatment option approved for BOTH bipolar I and bipolar II depression in adults. This non-CME educational program is sponsored by Intra-Cellular Therapies, Inc.

10-Minute Break

10:30 AM - 11:30 AM: Estrogen and Mood: Psychiatric Considerations Over the Reproductive Lifecycle – Presented by Jennifer Payne, MD

Dramatic hormonal changes surrounding reproductive life events such as menarche, pregnancy, and menopause are normal, yet only some women experience significant impact of these fluctuations on mood. This session explores the relationship between brain estrogen sensitivity and depression, including correlation of epigenetic biomarkers with clinical symptomatology.

11:30 AM - 12:30 PM: Agitation, Psychosis, and Other Behavioral Issues in Alzheimer’s Dementia – Presented by Anton Porsteinsson, MD

This presentation will describe the phenomenology, neurobiological mechanisms, and management of neuropsychiatric symptoms in Alzheimer's disease and other dementias, including agitation, psychosis, mood changes, and apathy. Overall management approaches, findings from treatment trials, and novel approaches in development will be discussed.

30-Minute Break & Lunch for in person attendees

1:00 PM - 2:00 PM: Non-CME Educational Session managed by MDOutlook / Clinical Care Solutions, a CEA Company

Long-Term Strategies in Treatment-Resistant Depression Sponsored by Johnson & Johnson – Presented by Heather Luing, MD and Stephen A. Givens, PhD, LPC, NCC

"Long-Term Strategies in Treatment-Resistant (TRD) Depression,” an educational program focusing on the continuing care of adult patients with TRD.
- Review a patient case study to define treatment-resistant depression (TRD)—patients with major depressive disorder (MDD) with an inadequate response to 2 or more oral antidepressants—and review some of their most important concerns
- Clinical efficacy data in TRD for SPRAVATO® (esketamine) CIII nasal spray
- 5+-year results from a long-term, open-label safety study of SPRAVATO®
- Factors to consider when starting patients on SPRAVATO®
- Important Safety Information

This non-CME educational program is sponsored by Johnson & Johnson.

10-Minute Break

2:10 PM - 3:40 PM: Innovation Insight: How are Novel Agents Reshaping Schizophrenia's Landscape? – Presented by John Kane, MD

In this session, participants will review the mechanism of disease of schizophrenia and hear about the potential impact of novel agents in changing the landscape of schizophrenia treatment in addressing symptom domains and adverse event profiles.

10-Minute Wellness Break

3:50 PM - 4:50 PM: Navigating Cannabis Use in Psychiatric Populations: Drug-Drug Interactions and Other Pharmacologic Considerations – Presented by John S Markowitz, PharmD

Increasing use of medical and recreational cannabis can lead to safety concerns if clinicians and patients are not aware of potential interactions with other medications. This session will cover potential cannabis-related drug-drug interaction concerns that may arise in psychiatric populations and present strategies for patient communication and education.

4:50 PM - 5:00 PM: Closing Remarks by Moderator Lisa Harding, MD

5:00 PM - 6:00 PM - Welcome Reception

In-person learners are invited to join us at the welcome reception, Friday evening after the first day of the conference. Connect with familiar colleagues, network with new faces, and spark meaningful conversation over food, music, and fun in this atmosphere of intellectual curiosity!

Saturday, December 7, 2024—Eastern Time Zone

7:30 AM - 8:00 AM: Registration and Breakfast

8:00 AM - 8:10 AM: Opening Remarks by Moderator Joseph Goldberg, MD

8:10 AM - 9:10 AM: A Pharmacologic View of Tardive Dyskinesia: Pathology and Treatment – Presented by Greg Mattingly, MD

This session will revisit the mechanism of action, molecular differences, and PK/PD of VMAT2 inhibitors. Clinical considerations for safety and efficacy in older populations as they relate to dosing/titration schedules in special populations with age-related changes in body composition, metabolism, and comorbidities will be discussed.

10-Minute Break

9:20 AM - 10:20 AM: Sutures, Psych, and Sobriety: Tying Together Psychiatric Post-op Support for At-risk Patients – Presented by Michael Sprintz, DO, DFASAM

Patients with SUDS have unique concerns about pain management and relapse when they are faced with surgery. Participants will gain practical insights on interprofessional communication strategies, advocating for their patients, and managing medications for SUDs throughout the surgical process.

10-Minute Wellness Break

10:30 AM - 11:30 AM: Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers – Presented by Lori L. Davis, MD

In this session, review the latest research exploring the underlying pathophysiology of PTSD and explore clinical evidence for approved and emerging treatments.

5-Minute Break

11:35 AM - 12:35 PM: Clusters of Concerns: Neurobiology and Treatment of Psychiatric Disorder Comorbidities – Presented by Vladimir Maletic, MD

In this session, we will dive into the neurobiological roots of psychiatric disorder comorbidities, discuss the complexities of comorbidities in differential diagnosis, and outline advanced strategies for managing psychiatric comorbidities.

20-Minute Break & Lunch for in person attendees

12:55 PM - 1:55 PM: Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail – Presented by Joseph Goldberg, MD

This interactive session offers a systematic approach to making decisions for patient care for steps beyond first and second line treatment options. This approach considers variables that are important to patients, to HCPs, and what the data tell us to arrive at our next shared decision for optimized patient care.

5-Minute Wellness Break

2:00 PM - 4:20 PM: From Pain to Purpose: The Intersection of Psychiatry, Pain Management, and Opioid Safety - Presented by Michael Sprintz, DO, DFASAM

This comprehensive, 2.5-credit hour session covers opioid use disorder and pain management with a focus on areas of interest to psychiatry HCPs. Through expert-led discussions, attendees will gain appreciation for the biopsychosocial model of pain and addiction, and explore the intersection of pain assessment and management with the psychiatry and addiction spaces helping to reinforce clinical strategies that will promote safe, effective, patient-centered care. This session fulfills 2.5 hours of DEA MATE Act requirements.

4:20 PM - 4:30 PM: Closing Remarks by Moderator Joseph Goldberg, MD

Location

Venue Name

The Diplomat Beach Resort

Address

The Diplomat Beach Resort
3555 South Ocean Drive
Hollywood, Florida 33019

Room Name

Great Hall 1 & 2

Event Manager Info

Secure your hotel room now!
Room rate is $289 per night plus a $29 and tax resort fee per night, charged on site.
The group rate will be offered 3 days pre and post the conference dates based on availability. The last day to book at this rate is Monday, November 11, 2024.
Reservations number 855-689-2911

CME/CE Info

Target Audience
This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

Discuss the latest advances in the pharmacologic management of psychiatric disorders
Implement evidence-based pharmacotherapy for treatment of psychiatric disorders
Individualize treatment choices for psychiatric disorders based on efficacy, safety, and patient characteristics

*Pain Management Topic Only
Target Audience

This program is designed to educate HCPs in the United States, particularly HCPs practicing in settings with multidisciplinary and interprofessional healthcare teams, including physicians, advanced practice nurses, physician associates, pharmacists, nurses, psychologists, social workers, dental professionals, and optometrists. Specialty areas include, but are not limited to, physiatry, psychiatry, neurology, family medicine, internal medicine, pain management, and surgery.

Learning Objectives
Upon completion of this activity, participants should be able to:

Identify fundamental concepts of pain management, including mechanisms of pain; risk factors for misuse, abuse, and opioid use disorder; and appropriate assessment of pain
Create an individualized, patient-specific pain treatment plan that safely and effectively integrates the range of therapeutic options, including initiating therapy, titrating, and discontinuing non-opioid medications and opioid analgesics
Design an individualized patient and caregiver education plan on the safe use, storage, and disposal of opioid analgesics and the role of reversal agents
Construct a systematic approach to screening for and appropriately managing patients with opioid use disorder

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 12.0 contact hours, including 12.0 hours of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 12.0 contact hours (1.2 CEUs) of the Accreditation Council for Pharmacy Education. UAN: will be specific to each topic

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 12.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 12.0 clinical continuing education credits.

Dental Professionals Continuing Education
*Pain Management Topic Only

Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Clinical Care Options, LLC designates this activity for 2.5 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Optometrist Continuing Education
*Pain Management Topic Only

Clinical Care Options, LLC designates this synchronous in-person/virtual activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Innovation Insight: How are Novel Agents Reshaping Schizophrenia's Landscape?; Clusters of Concerns: Neurobiology and Treatment of Psychiatric Disorder Comorbidities; Insights into Tardive Dyskinesia in Aging Populations; Agitation, Psychosis, and Other Behavioral Issues in Alzheimer’s Dementia; Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers; Sutures, Psych, and Sobriety: Tying together psychiatric post-op support for at-risk patients; Estrogen and Mood: Psychiatric Considerations Over the Reproductive Lifecycle; Navigating Cannabis Use in Psychiatric Populations: Drug-Drug Interactions and Other Pharmacologic Considerations; Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail; Do Obesity and Diabetes Mellitus Metastasize to the Brain? "Metaboptosis" and Implications for Potential Therapeutics in Psychiatry, has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Bristol Myers Squibb; Neurocrine Biosciences, Inc.; and Otsuka America Pharmaceutical, Inc. and Lundbeck.

*Pain Management Topic Only

Provided by Clinical Care Options, LLC and in partnership with the Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Clinical Education Alliance Terms and Conditions

These Terms of Use ("Terms") apply to your use of the websites, mobile applications and other resources provided by Clinical Education Alliance LLC (“CEA”) and its affiliates (referred to collectively as "CEA," "us," "we" and "our") that are intended for use by healthcare professionals, which we refer to as the "CEA Network," including the personalized information and services that meet the needs and interests of users of the CEA Network such as medical news, reference content, clinical tools, applications, sponsored programs, advertising, email communications, continuing medical education, market research opportunities and discussion forums (collectively, the "Services"). You will always be able to view the most current version of these Terms by clicking on the Terms of Use link at the bottom of any page of a CEA Network property. Note that these Terms do not apply to our properties and services that display a link to different terms of use. In the event that we expand the CEA Network through our acquisition of another company and/or its properties, that company may operate its properties subject to its own terms of use accessible via a link on such properties until we integrate its practices with ours, at which point a link to these Terms will be displayed on its properties. By using the Services, you agree to these Terms, whether or not you are a registered member of the CEA Network. These Terms govern your use of the Services and create a binding legal agreement that we may enforce against you in the event of a violation. If you do not agree to all of these Terms of Use, do not use the Services!

We reserve the right to change these terms from time to time. The most current version may be viewed by clicking on the “Terms of Use” link at the bottom of designated pages on the Clinical Education Alliance Sites. Use of the Clinical Education Alliance Sites after the effective date constitutes acceptance of the amended Terms of Use. When you leave a CEA Web site and go to another Web site, different terms apply and CEA has no responsibility or liability for any content on those sites.

Clinical Education Alliance Content

The Clinical Education Alliance Sites incorporate information, including modules, capsules, journal articles, medical news, references, interactive case studies, other continuing education material, downloadable software applications, advertising, and other healthcare information, which is intended for adults who are licensed healthcare professionals. This information is not intended to serve as a substitute for the healthcare professional’s clinical judgment. If you are a consumer who chooses to read this professional-level information on Clinical Education Alliance Sites, you should not use or rely on that information as professional medical advice or use it to replace any relationship with your physician or other qualified healthcare professional or any information they may have provided to you. For medical issues or concerns, including decisions about medications and other treatments, consumers should always consult their physician or, in serious cases, seek immediate assistance from emergency personnel.

The Content on the Clinical Education Alliance Sites is developed or selected in accordance with our published Editorial Policies. However, users access and use this material at their own risk. It is the reader’s job to evaluate the accuracy of any information and results from interactive programs found on the Clinical Education Alliance Site. If you are a healthcare professional, you should rely on your professional judgment in evaluating any and all information and confirm the information contained on the Clinical Education Alliance Sites with other sources and reliable third parties before basing any treatment or advice on it. If you are a consumer, you should evaluate the information together with your physician or another qualified healthcare professional.

DISCLAIMERS AND LIMITATIONS OF LIABILITY

THE CONTENT, APPLICATIONS, SOFTWARE, AND ALL OTHER MATERIAL ON THE CLINICAL EDUCATION ALLIANCE SITES ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. ALL WARRANTIES, EXPRESS OR IMPLIED, ARE HEREBY DISCLAIMED. CLINICAL EDUCATION ALLIANCE SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, INCLUDING, WITHOUT LIMITATION, PHYSICAL HARM OR INJURIES, LOST REVENUES, OR LOST PROFITS, RESULTING FROM THE USE OR MISUSE OF THE CLINICAL EDUCATION ALLIANCE SITES, OR ANY INFORMATION, APPLICATIONS, MATERIALS, OR SOFTWARE THEREON, EVEN IF CLINICAL EDUCATION ALLIANCE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, OR FOR ANY CLAIM BY ANOTHER PARTY. CLINICAL EDUCATION ALLIANCE DOES NOT WARRANT THAT THIS SITE OR ANY APPLICATIONS OR SOFTWARE WILL BE FREE OF BUGS, INACCURACIES, OR ERRORS, NOR DOES CLINICAL EDUCATION ALLIANCE WARRANT THAT ANY SITE, SOFTWARE, OR APPLICATION IS FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS.

A user’s use of the Clinical Education Alliance Sites, and any reliance on any materials, information, software, or applications, is at the user’s own risk. You agree that you hereby release Clinical Education Alliance and its affiliates, owners, respective directors, officers, employees, advertisers, authors, and contributors from any and all liability or obligations arising from the use of the Clinical Education Alliance Sites. A user’s sole remedy for any problem or concern is to exit the Web site or application. You agree that you will indemnify and hold Clinical Education Alliance harmless for any loss, damages, or liability suffered by Clinical Education Alliance as a result of your use of any Clinical Education Alliance Site or material, application, information, or software thereon or your submission of any material to Clinical Education Alliance. Clinical Education Alliance reserves the right to restrict or limit access to this Web site.

CEA Programs, Tools, and Databases

The Clinical Education Alliance Sites include interactive programs, clinical tools, and databases intended for the use of healthcare professionals. These materials are not intended as professional advice or recommendations of particular products. Physicians and other healthcare professionals who use our interactive programs, tools, or databases should exercise their own clinical judgment as to the results. Consumers who use the tools or databases do so at their own risk.

Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns or issues, including decisions about medications and other treatments, users should always consult their physician or other qualified healthcare professional.

Ownership of Clinical Education Alliance Sites—Copyright and Trademarks

The entire contents and design of the Clinical Education Alliance Sites, including the software applications, tools, and databases, are protected under US and international copyright laws. These materials are owned by CEA or its affiliates or are used with permission of their owners or as otherwise authorized by law. All rights are reserved, worldwide. You may look at the Clinical Education Alliance Sites, download individual articles or applications to your personal computer or handheld device, and print a reasonable number of pages for your own personal reference. You must not remove any copyright notices from our materials. We reserve all our other rights. This means you may not sell, rewrite, or modify any content or other material found on any Clinical Education Alliance Site, redistribute it, put it on your own Web site, or use it for any commercial purpose without our prior written authorization.

The names of the CEA products and services are protected by trademark laws in the United States. Any use of our trademarks or service marks requires prior written approval from CEA.

You may link to a CEA Web site if your Web site offers products, services, or information of interest to the professional healthcare community. You are not allowed to link to the Clinical Education Alliance Sites if you post illegal, obscene, or offensive content or if the link is likely to have a negative impact on CEA’s reputation. Any other use, such as framing any part of a CEA Web site or incorporating any CEA content into another Web site, product, or application, requires advance written permission from Clinical Education Alliance. Clinical Education Alliance assumes no responsibility for any Web sites or materials that are linked to Clinical Education Alliance Sites or materials.

Software Products and Applications

Clinical Education Alliance makes some software and accompanying documentation available for downloading from our Web sites and/or from iTunes. These materials are protected by copyrights under US and international law and are owned by Clinical Education Alliance or companies that have licensed the software to us. We do not transfer any ownership rights in software or documentation to you when you download it from our Web site and/or directly from iTunes. You may use the software and accompanying documentation for their intended purpose. You are not authorized to further copy or distribute the software and accompanying documentation, nor may you attempt to recreate or reverse engineer our software or applications. In addition, some software available for downloading from our Web sites and/or from iTunes is subject to US export controls. By downloading or using such software, you are representing to us that your download of such software complies with these controls.

US Government End Users

If you are affiliated with the US government, please note that the software and documentation available on our Web sites and/or directly from iTunes are “commercial items,” as that term is defined in 48 C.F.R. 2.101 (October 1995), consisting of “commercial computer software” and “commercial computer software documentation,” as such terms are used in 48 C.F.R. 12.212 (September 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1 through 227.7202-4 (June 1995), all US government end users acquire the software and documentation with only those rights set forth herein.

Social Media, Message Boards, and Forums

Clinical Education Alliance offers users the opportunity to engage in social media interactions with both experts and other users of the sites. As with other online social media, users must exercise sound judgment in both the information that they post and in how they assess the postings of other users. As such, users are expected to adhere to the social media recommendations made by the American Medical Association when utilizing the social media capabilities of CEA sites. In particular, users must be cognizant of standards of patient privacy and confidentiality that must be maintained in all environments and must not post identifiable patient information on CEA sites. In social media interactions, users must maintain appropriate boundaries of the patient–physician/care provider relationship in accordance with professional ethical guidelines just as they would in any other context. Users acknowledge that privacy settings are not absolute and that once on the Internet, content posted by them may be copied by third parties and republished out of the control of Clinical Education Alliance. Thus, users should routinely monitor their own Internet presence to ensure that the personal information and content that they post and, to the extent possible, that is posted about them by others is accurate and appropriate.

Users are expected to refrain from submitting comments or messages that are defamatory, hateful, or obscene or that harass others. Users may not impersonate any other person or violate any other person’s or entity’s legal rights or submit falsified credentials or experiences. Users agree that they will not submit any materials that violate or infringe any copyrights, trademarks, patents, trade secret, or other intellectual property rights of any third party. Clinical Education Alliance retains all copyrights in the content posted by users to its sites. Clinical Education Alliance may adopt additional rules to govern use of social media, message boards or forums, to which users will be subject.

Copyright and Other Legal Violations

If you believe that any material on this Web site infringes your copyright, please notify us as follows, under the Digital Millennium Copyright Act (“DMCA”). To notify us, the DMCA requires that you: 1. Send an email notice to Clinical Education Alliance at customersupport@clinicaloptions.com. 2. Include the following information in your email: a. Identify the copyrighted work(s) you claim is infringed; b. Identify the material you claim is infringing the copyright(s) and give enough information for Clinical Education Alliance to locate that material; c. Include a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf (the “Claimant”); d. Include the Claimant’s name, address, and telephone number(s); e. Include a statement that the Claimant has a good faith belief that use of the disputed material is not authorized by the copyright owner or his agent; and f. Include a statement, under penalty of perjury, that the information in the notification of copyright infringement is accurate and that the Claimant is the copyright owner or is authorized to act on behalf of the copyright owner.

If you believe any content or material on the Clinical Education Alliance Sites violates any laws, please notify customersupport@clinicaloptions.com. Please include details about your concerns and an email address for contacting you.

Governing Law

Clinical Education Alliance controls the Clinical Education Alliance Sites from its offices in the state of Virginia in the United States of America. The Clinical Education Alliance Sites can be accessed from any of the United States and from other countries worldwide. Since the laws of each state or country may differ, both you and Clinical Education Alliance agree that the laws of Virginia, without regard to conflicts of laws principles, will apply to all matters relating to use of the Clinical Education Alliance Sites and materials, including software and applications.

Clinical Education Alliance makes no representation that materials on these sites are appropriate or available for use in countries aside from the United States. Accessing the Clinical Education Alliance Sites from territories where their contents are illegal is prohibited. Those who choose to access these sites from other locations do so at their own risk and are responsible for compliance with any and all applicable local laws or regulations.

Acceptance Procedure

By downloading or accessing materials on the Clinical Education Alliance Sites and/or directly from iTunes or registering with us, you agree to all the terms and conditions in this agreement, including the Terms of Use and Privacy Policy. If you disagree with any of these Terms of Use or Privacy Policy, please refrain from using the Clinical Education Alliance Sites or materials.

Privacy Policy

Because we provide education for healthcare professionals, we pay special attention to privacy issues. The purpose of our Privacy Policy is to identify the information we may collect about you, describe the uses we may make of your information and the security measures we take to protect it, and discuss your options for controlling your information. You can review our Privacy Policy by clicking on the “Privacy Policy” link at the bottom of designated pages on the Clinical Education Alliance Sites.

Disputes

If you fail to comply with these terms, we have the right to suspend or eliminate your account and remove any information you have placed on our site, including your registration information. We may also take any legal action we think is appropriate. If there is any dispute between us concerning this agreement or your use of any Clinical Education Alliance Site or materials or applications, we both agree to submit the dispute to nonbinding mediation, followed by binding arbitration. Both the mediation and the arbitration will be governed under the rules of the American Arbitration Association, and the venue for the arbitration will be Virginia.

Questions or Concerns About Our Terms of Use

For questions or concerns about these Terms of Use, please send an email to customersupport@clinicaloptions.com

These terms of use were last updated in July 2021.

10th Annual Psychopharmacology Update 2024

Who Should Attend

Time and location

Faculty

Lori L. Davis, MD

Stephen A. Givens, PhD, LPC, NCC

Joseph F. Goldberg, MD

Lisa Harding, MD

John M. Kane, MD

Heather Luing, MD

Vladimir Maletic, MD, MS

John S. Markowitz, PharmD, BCPP

Greg W Mattingly, MD

Roger S. McIntyre, MD, FRCPC

Jennifer L. Payne, MD

Anton P. Porsteinsson, MD

Michael Sprintz, DO, DFASAM

Agenda

Location

Venue Name

Address

Room Name

Event Manager Info

CME/CE Info

Accreditation

Acknowledgement

Contact Information

Additional Information